DT
MCRB icon

Diversified Trust’s Seres Therapeutics MCRB Stock Holding History

Diversified Trust’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-500
Closed -$7K – 979
2025
Q1 		$7K Hold
500
– – ﹤0.01% 918
2024
Q4 		$8.31K Hold
500
– – ﹤0.01% 918
2024
Q3 		$9.46K Hold
500
– – ﹤0.01% 902
2024
Q2 		$7.24K Hold
500
– – ﹤0.01% 869
2024
Q1 		$7.74K Hold
500
– – ﹤0.01% 825
2023
Q4 		$14K Hold
500
– – ﹤0.01% 863
2023
Q3 		$23.8K Hold
500
– – ﹤0.01% 818
2023
Q2 		$47.9K Buy
+500
New +$54.4K ﹤0.01% 812

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Diversified Trust's MCRB Position: Q2 2025 in Review

Diversified Trust sold out of Seres Therapeutics (MCRB) in Q2 2025, closing a stake of 500 shares — an estimated $7K sold.

Diversified Trust first reported a position in MCRB in Q2 2023 and held it in 8 quarters. The position peaked at $47.9K in Q2 2023. 33 funds tracked by Wall St. Rank hold MCRB as of Q2 2025.

  • Diversified Trust reported no remaining Seres Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Diversified Trust sold 500 Seres Therapeutics shares in Q2 2025, an estimated $7K.
  • Diversified Trust first reported a position in Seres Therapeutics in Q2 2023 and held it in 8 quarters.
  • Diversified Trust's Seres Therapeutics position peaked at $47.9K in Q2 2023.
  • 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2025.

Based on Diversified Trust's 13F filing for Q2 2025, filed 11 Jul 2025.